Several distinct fibroblast subtypes reside within the interstitium of the lung. Activation of one or more of these fibroblast subtypes likely contributes to the pathogenesis of pulmonary fibrosis. In order to examine fibroblast heterogeneity, we will employ in our studies two fibroblast major subtypes which we have isolated from the neonate rat lung. We plan to examine the effects of important effector molecules such as platelet-derived growth factor and transforming growth factor-beta on these fibroblast subtypes. These substances are likely generated during inflammatory reactions following acute lung injury. In addition, we will evaluate the effects of defined matrix components and cell-cell interactions on the two fibroblasts subtypes. The effect of normal or bleomycin-injuried alveolar type 2 cells on the fibroblast subtypes will be assessed. We will determined whether either of the fibroblast subtypes is selectively stimulated by these experimental manipulations. A characteristic feature of the early fibrotic lesion is the appearance of the myofibroblast. The myofibroblast contains peripheral actin bundles and is associated with the deposition of type III collagen. The mechanisms which control the expression of the myofibroblast phenotype are unclear. We will examine the hypothesis that one of the fibroblast subtypes is modified to develop the myofibroblast phenotype by inflammatory mediators, defined matrix components or fibroblast-epithelial interactions. The distinct fibroblast subtypes will be examined morphologically and the synthesis of actin, fibronectin and collagen will be determined. The types of collagen synthesized will be characterized and the expression of mRNA for types I and III collagen synthesized will be assessed using cDNA probes. We will determine whether myofibroblasts isolated from bleomycintreated lungs resemble either of the fibroblast populations studied above. We expect that these studies will provide new insights into the pathogenesis of pulmonary interstitial fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039865-03
Application #
3356812
Study Section
(SRC)
Project Start
1987-09-30
Project End
1990-12-31
Budget Start
1989-09-30
Budget End
1990-12-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Berk, J L; Franzblau, C; Goldstein, R H (1991) Recombinant interleukin-1 beta inhibits elastin formation by a neonatal rat lung fibroblast subtype. J Biol Chem 266:3192-7
Villanueva, A G; Farber, H W; Rounds, S et al. (1991) Stimulation of fibroblast collagen and total protein formation by an endothelial cell-derived factor. Circ Res 69:134-41
Fine, A; Poliks, C F; Smith, B D et al. (1990) The accumulation of type I collagen mRNAs in human embryonic lung fibroblasts stimulated by transforming growth factor-beta. Connect Tissue Res 24:237-47
Goldstein, R H; Fine, A; Farnsworth, L J et al. (1990) Phorbol ester-induced inhibition of collagen accumulation by human lung fibroblasts. J Biol Chem 265:13623-8
Karlinsky, J B; Goldstein, R H (1989) Regulation of sulfated glycosaminoglycan production by prostaglandin E2 in cultured lung fibroblasts. J Lab Clin Med 114:176-84
Fine, A; Poliks, C F; Donahue, L P et al. (1989) The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts. J Biol Chem 264:16988-91
Goldstein, R H; Poliks, C F; Pilch, P F et al. (1989) Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 124:964-70